NEW YORK, Aug. 24, 2016 /PRNewswire/ -- Dipexium
Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical
company focused on the development and commercialization of
Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical
antibiotic peptide, today announced plans to participate in two
September investor conferences:
- Friday, September 9, 2016 at the
NewsMakers in the Biotechnology Industry Conference in
New York City. David P. Luci, President & Chief Executive
Officer, will present a corporate overview at 2:00 p.m. ET.
- Monday, September 12, 2016 at the
Rodman & Renshaw 18th Annual Global Investment
Conference in New York City.
David P. Luci, President & Chief
Executive Officer, will present a corporate overview at
12:05 p.m. ET.
To access the live audio webcasts of these presentations, please
log on through a link in the Investor Relations section of
Dipexium's website at www.dipexiumpharmaceuticals.com, under the IR
Calendar tab. A replay of the webcasts will be available for 30
days after the live events.
About Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) is a late-stage
pharmaceutical company focused on the development and
commercialization of Locilex® (pexiganan cream 0.8%), a novel,
broad spectrum, topical antibiotic peptide. Initially, Locilex® is
targeted for the treatment of mild infections of diabetic foot
ulcers. Based on a compilation of available clinical and
microbiology data, Locilex® is also considered a promising product
candidate to treat other mild and moderate skin and skin structure
infections, including infected decubitus ulcers, infected burns,
infected surgical wounds and nasal colonization of
methicillin-resistant staphylococcus aureus (MRSA). For more
information, visit www.dipexiumpharmaceuticals.com.
Company Contacts:
David P. Luci
President & Chief Executive Officer
Dipexium Pharmaceuticals, Inc.
212-269-2834
info@dipexium.com
David Garrett
Vice President, Finance & Corporate Development
Dipexium Pharmaceuticals, Inc.
212-269-2834
info@dipexium.com
© 2016 Dipexium Pharmaceuticals, Inc. All rights
reserved.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dipexium-pharmaceuticals-announces-participation-in-september-investor-conferences-300317306.html
SOURCE Dipexium Pharmaceuticals, Inc.